Nonpharmaceutical fentanyl-related deaths - Multiple states, April 2005-March 2007

Morbidity and Mortality Weekly Report

Volumn 57, Issue 29, 2008, Pages 793-796

  Jones, T S ^a   Krzywicki, L ^b   Maginnis, J ^b   Jones, N L ^c   Weiskopf, R ^d   Reid, M ^e   Schmidt, C ^f   Fiedler, J ^g   Topolski, J M ^h   Graham, M ⁱ   Psara, R ⁱ   Case, M ⁱ   McCune, S ⁱ   Marcus, S M ^j   Weedn, V W ^k   Hempstead, K ^l   Klein, S J ^m   Roseborough, G ⁿ   Alles, S ^o   Nalluswami, K ^p   Kelly, S ^q   Zobeck, T ^q   McCormick, T ^r   Peters, D ^s   Wilson, M ^s   Regula, E ^t   Hoffman, K ^u   Lentine, D ^v   more..

^a T Stephen Jones Public Health Consulting   (United States)

^b Delaware Information and Analysis Center   (United States)

^c Office of the Medical Examiner   (United States)

^d Illinois Dept of Human Svcs

^e Detroit Wayne County Community Mental Health Agency

^f Office of Chief Medical Examiner   (United States)

^g MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^h MISSOURI INSTITUTE OF MENTAL HEALTH   (United States)

ⁱ St Louis City Medical Examiner's Office   (United States)

^j RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^k New Jersey Office of the State Medical Examiner

^l Center for Health Statistics

^m NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

ⁿ Office of the Attorney General

^o PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^p PENNSYLVANIA DEPARTMENT OF HEALTH   (United States)

^q Office of National Drug Control Policy

^r Chicago Office   (United States)

^s Office of Diversion Control

^t Drug Enforcement Administration   (United States)

^u Div of Pharmacologic Therapies

^v CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HUMAN; INTOXICATION; MALE; MIDDLE AGED; MORTALITY; OPIATE ADDICTION; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; OVERDOSE; UNITED STATES;

EID: 47949103269     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. US Department of Justice, Drug Enforcement Administration. 21 CFR part 1310. Control of a chemical precursor used in the illicit manufacture of fentanyl as a list 1 chemical. Federal Register 2007;72:20039-47. Available at http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?db name= 2007_register&position=all&page=20039.
2. Thompson JG, Baker AM, Bracey AH, et al. Fentanyl concentrations in 23 postmortem cases from the Hennepin County Medical Examiner's Office. J Forensic Sci 2007;52:978-81.
3. Henderson GL. Designer drugs: past history and future prospects. J Forensic Sci 1988;33:569-75.
4. Poklis A. Fentanyl: a review for clinical and analytical toxicologists. J Toxicol Clin Toxicol 1995;33:439-47.
5. Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health 2005;82:303-11.
6. CDC. CDC Wonder. Compressed mortality file, 1999-2005. Available at http://wonder.cdc.gov/cmf-icd10.html.
7. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006;15:618-27.
8. CDC. Unintentional poisoning deaths - United States, 1999-2004. MMWR 2007;56:93-6.
9. Fielden SJ, Marsh DC. It's time for Canadian community early warning systems for illicit drug overdoses [Commentary]. Harm Reduct J 2007;4:10.
10. Klein SJ, O'Connell DA, Candelas AR, Giglio JG, Birkhead GS. Public health approach to opioid overdose [Letter]. Am J Pub Health 2007;97:587-8.